about
A novel therapeutic effect of statins on nephrogenic diabetes insipidusA Point Mutation in p190A RhoGAP Affects Ciliogenesis and Leads to Glomerulocystic Kidney DefectsProtective effects of the mTOR inhibitor everolimus on cytoskeletal injury in human podocytes are mediated by RhoA signalingAdipose tissue, obesity and adipokines: role in cancer promotionPodocyte biology and pathogenesis of kidney diseaseFragility of foot process morphology in kidney podocytes arises from chaotic spatial propagation of cytoskeletal instability.Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy.Rhophilin-1 is a key regulator of the podocyte cytoskeleton and is essential for glomerular filtration.IQGAP1 regulates actin cytoskeleton organization in podocytes through interaction with nephrinGq signaling causes glomerular injury by activating TRPC6.KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.Circulating Fibroblast Growth Factor-2, HIV-Tat, and Vascular Endothelial Cell Growth Factor-A in HIV-Infected Children with Renal Disease Activate Rho-A and Src in Cultured Renal Endothelial Cells.Progress in pathogenesis of proteinuria.Dexamethasone-dependent modulation of cyclic GMP synthesis in podocytes.Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.Cyclosporine A protects podocytes by regulating WAVE1 phosphorylation.Current concepts of the podocyte in nephrotic syndrome.ARHGDIA: a novel gene implicated in nephrotic syndromeCdc42 deficiency induces podocyte apoptosis by inhibiting the Nwasp/stress fibers/YAP pathway.Dosage-dependent role of Rac1 in podocyte injury.Inverted formin 2 regulates actin dynamics by antagonizing Rho/diaphanous-related formin signaling.Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular signal-regulated kinases 1/2 (ERK1/2)Circulating permeability factor suPAR: from concept to discovery to clinic.Loss of endogenous thymosin β4 accelerates glomerular disease.Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease.Cell-matrix adhesion of podocytes in physiology and disease.Rho kinase inhibition in diabetic kidney disease.Role of Rho-GTPases and their regulatory proteins in glomerular podocyte function.The pathogenesis of focal segmental glomerulosclerosis.MAGI2/S-SCAM outside brain.Targeting the podocyte cytoskeleton: from pathogenesis to therapy in proteinuric kidney disease.Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.Podocyte-actin dynamics in health and disease.Role of Protein Kinase G and Reactive Oxygen Species in the Regulation of Podocyte Function in Health and Disease.Steroid-resistant nephrotic syndrome: a persistent challenge for pediatric nephrology.MAGI2 Mutations Cause Congenital Nephrotic Syndrome.RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways.The podocyte cytoskeleton in health and in disease.Human Kidney Disease-causing INF2 Mutations Perturb Rho/Dia Signaling in the Glomerulus.Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy.
P2860
Q27005638-355E5CF9-019D-4042-AFDE-2F3DF88F97DEQ27309265-61AEFEDD-6EB0-4C2D-AA9D-D0C468C509E1Q27315815-11C45B81-2988-4A54-A86F-F6354E2F3519Q28086997-0BB45854-CEB3-45AC-83DC-6675E1997746Q30424169-250E3058-0403-4F8F-8615-16F9B32047FBQ30843363-D8AF9CA6-7565-4D1E-BFC6-44B87C2B22DFQ34302891-84E89579-BF5C-4A7E-AAF7-0ADF6E8B7570Q35124219-7B1F224D-2AFA-472F-9F89-8EA8531AB4B7Q35169561-5C5F3067-6A6F-4213-BA5B-0BBED0B08CE2Q35719874-E8CBC2D3-50F0-4DAE-A25E-3C3BF7A92580Q35836132-838841DF-481C-4C86-840E-A489A6AD1D7FQ35994961-79B75577-F58A-4084-B49C-2B708F0DA120Q36011008-A5097F9F-B345-491C-B3B1-D15F9CA73B73Q36109237-CD39B9DF-DC5A-4056-86B7-96399056F8FAQ36297539-57C5263E-FFBE-462A-AFEB-0DD844B7FAB8Q36346375-A76D4059-297E-4103-B48D-4A6E43FED6E7Q36468648-3CA5E5AB-774F-4C7B-AC15-93AF1B945AAEQ36764175-6604EEE1-51FF-4D17-8466-AF9125EF0E74Q36774995-76939251-D425-4F9D-8828-18F3CE56AF5EQ36810711-6B58274A-1DB4-4AED-A2B1-B8C881FB7847Q36880430-E39B020A-4436-42B7-9208-ACF5A991E9D8Q36947844-9048BA5F-45D5-41F8-A4FA-C16EF452CAB2Q37026094-737B63D6-1C9F-495A-8794-CD930FC25AE5Q37354989-3616D045-3082-4F65-AC84-E4325D7DF0DCQ38072297-98708D76-06B7-4080-8B4B-4C4647EC7924Q38075788-2884E774-AEBD-4A62-BA0C-7CB0E09CE507Q38117171-B4CE2FF1-DFCA-4690-B05D-2D35217D2222Q38154296-E1291EDE-59F9-4863-A4BF-E66980504353Q38244352-6636E564-7389-4B3A-A033-ECEB70EB6A0DQ38338534-7870325C-CE9A-464B-AA55-82941D350DB6Q38770231-4B238BF5-366A-4E2B-BD09-8D25D9AA431BQ38793769-AA255840-59EF-46E6-846A-438A19ECD0B8Q38940494-A537E700-4952-47D5-B4B0-9C4F54A5E604Q38962889-FDA56B32-92A1-479E-B217-7C34185FCEC3Q38991259-D30169BA-3126-4A0A-B0E5-FA4E74D3D619Q39118036-1D1B55A8-D8F3-4015-8C42-86B7B4307C35Q39255682-8F9879E6-FEFF-4B50-B8F7-A9345A692A55Q39721946-629B4E3F-1A5E-45C6-BD14-7B5BD624245AQ40824690-40E59D8F-98A9-4ED2-92BF-CB0ACCA4452BQ41169241-86F2BE71-1A51-48B6-92E9-872A43046A3E
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mechanisms of the proteinuria induced by Rho GTPases.
@ast
Mechanisms of the proteinuria induced by Rho GTPases.
@en
type
label
Mechanisms of the proteinuria induced by Rho GTPases.
@ast
Mechanisms of the proteinuria induced by Rho GTPases.
@en
prefLabel
Mechanisms of the proteinuria induced by Rho GTPases.
@ast
Mechanisms of the proteinuria induced by Rho GTPases.
@en
P2093
P2860
P356
P1433
P1476
Mechanisms of the proteinuria induced by Rho GTPases.
@en
P2093
David N Howell
Jose A Gomez
Liming Wang
Mathew J Ellis
Phillip Ruiz
Robert F Spurney
Timothy A Fields
Walter Fennell
William Eisner
P2860
P2888
P304
P356
10.1038/KI.2011.472
P407
P577
2012-01-25T00:00:00Z